Key result
The abstract provides only background information on the perioperative use of non-steroidal anti-inflammatory drugs without reporting any study findings.
Observational
NSAIDs prescribed mainly to younger, lower-ASA patients; this Level 5 audit leaves open whether selected higher-risk cases could safely receive them.
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used as part of a multimodal approach to perioperative analgesia owing to their anti-inflammatory and opiate-sparing benefits.1 As cyclo-oxygenase (COX) inhibitors, they prevent the production of prostaglandins which are a key component of the inflammatory process. There are two main classes of NSAIDs: non-selective COX inhibitors (e.g. ibuprofen) that inhibit both COX-1 and COX-2, and COX-2-specific inhibitors (e.g. parecoxib).
No takes yet. Share an insight, caveat, or question.
Andrew Richardson (2025) conducted an observational in Perioperative analgesia. Non-steroidal anti-inflammatory drugs (NSAIDs) was evaluated. The abstract provides only background information on the perioperative use of non-steroidal anti-inflammatory drugs without reporting any study findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: